The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,886,702 in first-year total cost, median $815,497.
Most frequent study sections
- Special Emphasis Panel[ZCA1 GRB-S (M1)]17
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES3
- DANA-FARBER CANCER INST2
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL2
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Identifying the mechanisms of leukemia progression1R35CA253096-01A1 | CRISPINO, JOHN D | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $1,077,000 | ZCA1 |
| 2021 | Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer2R35CA197583-08 | WALENSKY, LOREN DAVID | DANA-FARBER CANCER INST, MA | $1,071,751 | ZCA1 |
| 2021 | Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery2R35CA197568-08 | MEYERSON, MATTHEW L. | DANA-FARBER CANCER INST, MA | $1,068,000 | ZCA1 |
| 2021 | Novel therapeutic development for small cell lung cancer1R35CA263816-01 | RUDIN, CHARLES M. | SLOAN-KETTERING INST CAN RESEARCH, NY | $1,062,000 | ZCA1 |
| 2021 | Metabolic gatekeepers in B-cell malignancies2R35CA197628-07 | MÜSCHEN, MARKUS | YALE UNIVERSITY, CT | $1,005,000 | ZCA1 |
| 2021 | Molecular strategies for early detection and targeting of cancer2R35CA197699-07 | REYA, TANNISHTHA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $975,945 | ZCA1 |
| 2021 | Towards a quantitative understanding of tumor evolution1R35CA253126-01A1 | RABADAN, RAUL | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $972,000 | ZCA1 |
| 2021 | Regulatory T cells and the tumor microenvironment1R35CA263850-01 | VIGNALI, DARIO AA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $927,924 | ZCA1 |
| 2021 | Determinants of response to cancer immunotherapy1R35CA253175-01A1 | FONG, LAWRENCE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $815,497 | ZCA1 |
| 2021 | Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting1R35CA253127-01A1 | STEIDL, ULRICH | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $776,201 | ZCA1 |
| 2021 | Integrating systems immunology with immunometabolism and cancer immunity1R35CA253188-01A1 | CHI, HONGBO | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $730,271 | ZCA1 |
| 2021 | Understanding and targeting the DNA replication stress in cancer cells1R35CA263934-01 | ZOU, LEE | MASSACHUSETTS GENERAL HOSPITAL, MA | $704,285 | ZCA1 |
| 2021 | Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors1R35CA253183-01A1 | IAVARONE, ANTONIO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $663,188 | ZCA1 |
| 2021 | Understanding and exploiting DNA topoisomerases in cancer biology1R35CA263778-01 | BERGER, JAMES M. | JOHNS HOPKINS UNIVERSITY, MD | $657,741 | ZCA1 |
| 2021 | p53-mediated metabolic regulation in tumor suppression1R35CA253059-01A1 | GU, WEI | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $570,812 | ZCA1 |
| 2021 | The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer1R35CA253119-01A1 | HOLLAND, ERIC C. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $485,162 | ZCA1 |
| 2021 | Metabolic reprogramming of the tumor microenvironment and therapy resistance1R35CA264619-01 | LENGYEL, ERNST | UNIVERSITY OF CHICAGO, IL | $323,925 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.